Marcus Drake is Professor of Physiological Urology at the University of Bristol, and Honorary Consultant Surgeon at the Bristol Urological Institute. He is Associate Director of Research for the NHS Hospitals in Bristol. He is academic lead of the final year at Bristol Medical School. He undertook his medical training at the Universities of Cambridge and Oxford and was awarded his research Doctorate Thesis by the University of Oxford. His clinical interests in Urology are Urodynamics, Neuro-urology, LUTS and Nocturia.
He is Chief Investigator of UK National Institute of Health Research grants in Male LUTS (HTAs UPSTREAM & TRIUMPH), Nocturia (RfPB PLANET), catheter design (RfPB Flume), recurrent stress incontinence (HTA PURSUIT), and UTI diagnostics (i4i QUICK). He is co-CI of an NIH RO1 grant in Physiology (sildenafil effects on voiding). He was CI of the MeNiMS study of nocturia in MS. He was CI of the pharmaceutical trials BESIDE and NEPTUNE2. He is co-investigator for NIHR studies in male stress incontinence (HTA MASTER), urodynamics (HTAs FUTURE & PRIMUS), and preparation for surgery (HTA INSPIRE) and the UK EPSRC emPOWER study. His total cumulative career grant awards are £33M, of which £10M are as CI.
He is a Trustee of the International Continence Society. He is a board member of the European Society of Female and Functional Urology. He was Chairman of the International Continence Society’s Standardisation Steering Committee for 6 years, and board member of the European School of Urology for 8 years. He was a member of the European Association of Urology Guidelines committee for male LUTS. He has recently completed writing the 4th Edition of “Abrams’ Urodynamics”